ARCHIVES

As Zeneca Buys Salick, Implications For Oncology Managed Care Uncertain

This article is from The Cancer Letter archive.

Vol. 23 No. 13 | April 4, 1997

Download PDF Visit The Full Archive

Related Articles

Study: Ibrutinib Lowers IgM, Bone Marrow Disease Burden

July 26, 2013

Facilities Survey To Include All Institutions With $200,000 Or More in NCI Support

October 5, 1984

ASCO Annual Meeting: New Regimens Promising For Metastatic Colon Cancer

July 28, 2006

Clinton Budget Provides 4.7% Increase For NIH; $118 Million Raise for NCI

February 11, 1994

New RFAs on Retinoids & Carotenoids, Tobacco, NMR Research Resistance

July 27, 1984

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009